Cell-Type Specific Behavioral and Molecular Characterization of Fear Controlling Amygdala Sub-Populations Open Access

McCullough, Kenneth (2017)

Permanent URL: https://etd.library.emory.edu/concern/etds/db78tc77z?locale=en
Published

Abstract

Behavioral and molecular characterization of cell-type specific populations governing fear learning and related behaviors is a promising avenue for the identification of more targeted therapeutics for the treatment of fear-related disorders such as Posttraumatic Stress Disorder. In the amygdala, a number neuronal of sub-populations within previously identified nuclei have been identified by their distinct mRNA and protein expression profiles. These sub-populations appear to differentially regulate fear behaviors by supporting the learning and expression of fear or by inhibiting fear expression and supporting fear extinction. Here, we approach the identification, behavioral characterization and molecular characterization of potentially behaviorally relevant amygdala sub-populations in three ways. First, we perform an in-depth analysis of the expression and co-expression of six mRNA markers that may relate to behaviorally relevant functional sub-populations within the central amygdala (CeA). Second, we perform an in-depth behavioral and molecular characterization of one such CeA population, the dopamine receptor 2 (Drd2) expressing population. Third, we behaviorally and molecularly characterize a fear inhibiting population, the Thy-1 population, found within the basolateral amygdala (BLA).

In our characterization of CeA sub-populations, we find that within the lateral compartment of the central amygdala (CeL), Somatostatin (Sst), Tachykinin (Tac2) Neurotensin (Nts) and Corticotropin releasing factor (Crf) mRNAs mark a single convergent population; however, within the medial compartment of the central amygdala (CeM) these RNAs mark independent populations. Additionally, protein kinase C delta (Prkcd) and Drd2 mRNAs mark non-overlapping sub-populations within the capsular compartment of the central amygdala (CeC) and CeL. Further characterization of the CeA Drd2 population identifies this population as a fear-supporting population whose activity is sufficient to enhance fear expression and block fear extinction. Cell-type specific characterization of actively translating RNAs using translating ribosome affinity purification (TRAP) reveals that Sst5r, Npy5r, Fgf3, ErbB4, Fkbp14, Dlk1, Ssh3 and Adora2a are each differentially regulated within Drd2 neurons following fear conditioning. Pharmacological manipulation of Drd2 neurons through D2R and A2AR recapitulate fear-supporting profile observed with direct chemogenetic activation. Finally, using optogenetics and chemogenetics we identify the Thy-1 population of the BLA as a fear-inhibiting population. Isolation and sequencing of RNA from Thy-1 neurons reveals Ntsr2, Dkk3, Rspo2, and Wnt7a as being upregulated in Thy-1 neurons compared to other amygdala neurons. Pharmacological activation of NTSR2 is sufficient to recapitulate fear-suppression profile observed using direct manipulations of this population. Our efforts have clarified the identities of sub-populations of the CeA and provided important molecular characterizations of crucial fear-controlling populations of the CeA and BLA.

Table of Contents

Chapter Index

Chapter 1: Introduction: Bridging the Gap: Towards a Cell-Type Specific Understanding of Neural Circuits Underlying Fear Behaviors. 16

1.1 Context, Author's Contribution and Acknowledgement of Reproduction. 17

1.2 Abstract. 17

1.3 Introduction.. 18

1.4 Background on Circuitry and Fear. 20

Pavlovian Conditioning. 20

Fear learning: Basic Circuitry and Key Players. 21

1.5 Optogenetic Tracing of Fear Circuitry. 24

Inputs to Lateral Amygdala. 26

Studies focused on Basolateral Amygdala. 27

Studies Focused on Medial Prefrontal Cortex. 29

The Central Nucleus of the Amygdala. 30

The Intercalated Cell Masses. 31

Bed Nucleus of the Stria Terminalis. 32

1.6 Search for the Memory Engram... 33

1.7 Cell Type Specific Targeting of Behavioral Processes. 36

Differential Molecular Markers of Central Amygdala Cell Types: PKCd, Sst, and Tac2 39

The Parabrachial Nucleus and Calcitonin Gene-Related Peptide. 42

BLA Inhibitory Neuronal Sub-Populations: PV and SOM... 43

Thy1-Population of Pyramidal BA Neurons. 44

Hypothalamic Sub-Populations: OT, ESR1, SF1. 45

Alternative Targets. 47

1.8 Cell-Type Specific Transcriptome Sequencing. 48

1.9 Summary. 51

Chapter 2: Co-Expression Analysis of Prkcd, Sst, Tac2, Crf, Nts and Drd2 Sub-Populations Within the Central Amygdala. 57

2.1 Context, Author's Contribution and Acknowledgement of Reproduction. 58

2.2 Abstract. 58

2.3 Introduction.. 59

2.4 Results. 62

Distribution of Labeled Cells. 63

Prevalence of Labeled Cells. 64

Co-localization of CeA Markers. 64

2.5 Discussion.. 67

2.6 Methods. 70

RNA Scope Staining. 70

Image Acquisition.. 71

Data Analysis. 71

Statistical Analysis. 71

2.7 Figures. 73

Chapter 3: Behavioral and Molecular Characterization of Central Amygdala Dopamine Receptor 2 Expressing Neurons' Role in Fear Behavior. 84

3.1 Context, Author's Contribution and Acknowledgement of Reproduction.. 85

3.2 Abstract. 85

3.3 Introduction.. 86

3.4 Results. 89

Examination and Cell-Type Specific Manipulation of CeA Drd2 Population. 89

Characterization of Dynamic mRNA Changes in Drd2 Cells After Fear Conditioning. 91

Manipulation of A2A Receptor During Fear Behavior. 92

Examination of Role of D2R in Fear Learning and Extinction. 93

Dynamic Regulation of Drd2 After Fear Extinction. 94

Examination of Role of D2R in Consolidation of Extinction Learning. 95

3.5 Discussion.. 96

3.6 Methods. 99

Animals. 99

Surgical Procedures. 100

Drug Administration.. 100

Behavioral Assays. 101

Auditory Cue-Dependent Fear Conditioning. 101

Auditory Cue-Dependent Fear and Extinction.. 101

Open Field. 101

Brain Collection Following Behavior. 101

Real Time PCR.. 102

RNA-Seq Library Preparation.. 102

Analysis of RNA Sequencing Data. 103

Translating Ribosome Affinity Purification.. 103

Statistics. 103

RNA Scope Staining. 104

Image Acquisition.. 104

3.7 Figures. 105

Chapter 4: Molecular Characterization of a ‘Fear-Off' Neuronal Population within the Basolateral Amygdala. 116

4.1 Context, Author's Contribution and Acknowledgement of Reproduction. 117

4.2 Abstract. 117

4.3 Introduction.. 118

4.4 Results. 120

Thy1 Marks Consistent Population of BLA Neurons. 120

Separate Neuron Populations Active During Fear Processes. 122

Electrophysiological Characterization of Thy1-eNpHR Neurons. 123

Optogenetic Silencing of Thy1 Neurons. 123

Chemogenetic Activation of Thy1 Neurons. 125

Isolation and Molecular Characterization of Thy1 Neurons. 126

Pharmacological Manipulation of Neurotensin Receptor 2. 129

Examination of Projection Patterns of BLA Thy1-Cre Neurons. 131

4.5 Discussion.. 133

4.6 Methods. 136

Animals. 136

Surgical Procedures. 136

Laser Delivery. 137

Drug Administration.. 138

Behavioral Assays. 138

Auditory Cue-Dependent Fear Conditioning. 138

Auditory Cue-Dependent Fear Expression and Extinction.. 138

Behavioral Tests For c-fos Expression Experiments. 139

Open Field. 139

Dissociation of Amygdala Tissue for FACS. 139

Immunolabeling Cell Suspension for FACS. 140

Flow Cytometry. 140

Real Time PCR.. 141

Immunohistochemistry. 141

RNA-Seq Library Preparation.. 142

Analysis of RNA Sequencing Data. 142

Statistics. 143

Analysis of BLA Thy1-Cre Projections. 143

4.7 Figures. 144

4.8 Supplemental Discussion.. 155

4.9 Supplemental Figures. 161

Chapter 5: Conclusion, Discussion and Future Directions. 176

5.1 Summary of Results. 177

5.2 Integration of Findings. 179

5.3 Future Directions. 180

References. 185

Figure Index

Figure 1‑1. Neural circuits involves in fear and anxiety-related behaviors in rodents. 52

Figure 1‑2. Microcircuits and specific neuronal populations in the amygdala, ventromedial hypothalamus (VMH) and parabrachial nucleus (PBN) involved in fear and anxiety-related behaviors. 53

Figure 2‑1. Distribution of examined mRNAs across CeA sub-compartments. 73

Figure 2‑2. Co-expression of Sst, Tac2 and Prkcd (A-P -1.5). 74

Figure 2‑3. Co-expression of Crf, Nts and Prkcd (A-P -1.5). 75

Figure 2‑4. Co-expression of Sst and Nts, and Crf and Tac2 (A-P -1.5). 77

Figure 2‑5. Co-expression of examined mRNA's in anterior CeA (A-P -.9, -.8, and -1.22). 80

Figure 3‑1. Examination and cell-type specific manipulation of CeA Drd2 population. 105

Figure 3‑2. Examination of cell-type specific mRNA changes after fear conditioning. 107

Figure 3‑3. Selective blockade of A2AR blunts fear expression and enhances extinction consolidation. 109

Figure 3‑4. Blockade of Drd2 during extinction with common psychosis and MDD treatment, Sulpiride, enhances fear expression and within session extinction. 110

Figure 3‑5. Dynamic role of Drd2 during fear extinction. 112

Figure 4‑1. Thy1 lines mark BLA population that is active during expression of fear extinction. 144

Figure 4‑2 Halorhodopsin inhibition of BLA Thy-1 neurons. 146

Figure 4‑3. In Vivo inhibition of Thy1 neurons. 148

Figure 4‑4. Enhancing excitability of BLA Thy1 neurons using DREADDs. 150

Figure 4‑5. Workflow describing FACS sorting and sequencing of RNA of Thy1-eYFP cell bodies Cell-type specific RNA sequencing and identification of differentially regulated gene transcripts. 151

Figure 4‑6. Molecular characterization of basolateral amygdala Thy1 neurons. 153

Figure 4‑7. Modulating Neurotensin Receptor 2 activity alters fear expression and consolidation. 155

Figure 5‑1. Summary of Findings. 179

Supplemental Figure Index

Supplemental Figure 2‑1. Comparison of mouse brain atlases. 83

Supplemental Figure 3‑1. Fear conditioning of mice for TRAP collection. 114

Supplemental Figure 3‑2. Validation of TRAP pull-down. 114

Supplemental Figure 3‑3. Sulpiride effects on fear extinction rate. 115

Supplemental Figure 4‑1. Schematic of fiber optic fiber tip placement. 161

Supplemental Figure 4‑2. Genetic effects are not responsible for changes in fear expression of Thy1-eNpHR mice. 162

Supplemental Figure 4‑3. Flow chart of strategy for analysis of RNA sequencing differential expression data. 163

Supplemental Figure 4‑4. Replication of RNA sequencing results with qPCR. 164

Supplemental Figure 4‑5. Co-localization of Thy1-eYFP with additional differentially expressed genes. 165

Supplemental Figure 4‑6. Quantification of co-localization between Thy1-eYFP and additional proteins of interest. 166

Supplemental Figure 4‑7. Regional similarities in Thy1-eYFP, NTSR2, and DKK3 expression. 167

Supplemental Figure 4‑8. Differences in fear behavior after drug delivery are not due to anxiety like behavior after drug administration. 168

Supplemental Figure 4‑9. Infusion of AAV-DIO-YFP into Anterior BLA Thy1-Cre mouse. 169

Supplemental Figure 4‑10. Infusion of AAV-DIO-YFP into BLA Thy1-Cre mouse. 171

Supplemental Figure 4‑11. Infusion of AAV-DIO-YFP into Posterior BLA Thy1-Cre mouse. 172

Supplemental Figure 4‑12. Infusion of BDA into Anterior BLA. 173

Supplemental Figure 4‑13. Infusion of BDA into Posterior BLA. 174

Supplemental Figure 4‑14. Regional specificity of cre-recombinase mediated mCherry expression. 174

Supplemental Figure 4‑15. Double transgenic Thy1-eYFP/ Thy1-Cre mice have red-shifted expression in Thy1-eYFP neurons. 175

Index of Tables

Table 1.1 Descriptions of publications using optogenetics to query basic fear-related circuitries 54

Table1.2 Descriptions of publications using cell-type specific methodologies to query fear related circuitry. 56

About this Dissertation

Rights statement
  • Permission granted by the author to include this thesis or dissertation in this repository. All rights reserved by the author. Please contact the author for information regarding the reproduction and use of this thesis or dissertation.
School
Department
Subfield / Discipline
Degree
Submission
Language
  • English
Research field
Keyword
Committee Chair / Thesis Advisor
Committee Members
Last modified

Primary PDF

Supplemental Files